| NAFLD | Nonalcoholic fatty liver disease |
| SS | Simple steatosis |
| NASH | Nonalcoholic steatohepatitis |
| NW | Normal-weight |
| MO | Morbid obesity |
| NL | Normal liver |
| TLR2 | Toll-like receptor 2 |
| TLR4 | Toll-like receptor 4 |
| TLR9 | Toll-like receptor 9 |
| BMI | Body mass index |
| HOMA2-IR | Homeostatic model assessment method-insulin resistance |
| HbA1c | Glycosylated hemoglobin |
| HDL-C | High-density lipoprotein cholesterol |
| LDL-C | Low-density lipoprotein cholesterol |
| AST | Aspartate aminotransferase |
| ALT | Alanine aminotransferase |
| GGT | Gamma-glutamyl transferase |
| ALP | Alkaline phosphatase |
| IL-1β | Interleukin 1beta |
| IL-6 | Interleukin 6 |
| IL-7 | Interleukin 7 |
| IL-8 | Interleukin 8 |
| IL-10 | Interleukin 10 |
| IL-13 | Interleukin 13 |
| IL-17 | Interleukin 17 |
| IL-22 | Interleukin 22 |
| TNF-α | Tumor necrosis factor alpha |
| tPAI-1 | Total plasminogen activator inhibitor 1 |
| MCP-1 | Monocyte chemo attractant protein 1 |
| TGF-β | Transforming growth factor beta |